How SmartSignals Supplies Cut Annual Budgets for AstraZeneca & MedImmune Date Published: Apr 09, 2020 Case Study AstraZeneca & MedImmune chose Signant’s Forecasting, a web-enabled solution, to effectively forecast clinical supplies requirements and aggregate all supply and demand data into one convenient system. Although traditionally managed with independent projects or inefficient spreadsheets, clinical supply forecasting can cut costs and accelerate study startup times when in a digital format. When you choose Signant for your forecasting needs, your team will gain a live view of the supply position in each clinical trial. Learn more about the Forecasting solution and how it works. Download Now Share: LinkedInTweet Recommended Resources Article Patient-Enhanced Drug Discovery and Development This PharmaVoice article argues that patients should be viewed as partners in drug development. While big pharma companies are incorporating... Read More How EDC Can Support Modern Clinical Trials Watch Now Webinar Signant SmartSignals RTSM: Randomization and Cohort Management, IP Inventory Management Download Now Case Study